Bimodal AIDS vaccine approach: Induction of cellular as well as humoral immunity can protect from systemic infection

Vaccine

Volumn 28, Issue SUPPL. 2, 2010, Pages

  Rasmussen, Robert A ^a,b   Lakhashe, Samir K ^a,b   Ruprecht, Ruth M ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Animal model; HIV clade C; Multimeric gp160; Protein immunization; R5 SHIV; Vaccine

Indexed keywords

ANTIGEN; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION;

AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MACACA MULATTA; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; VIRAL LOAD;

EID: 77952528116     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.131     Document Type: Article

References (28)

1. Steinbrook R. One step forward, two steps back-will there ever be an AIDS vaccine?. N Engl J Med 357 December (26) (2007) 2653-2655
2. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009 Nov 9 [Epub ahead of print].
3. Kramer V.G., Siddappa N.B., and Ruprecht R.M. Passive immunization as tool to identify protective HIV-1 Env epitopes. Curr HIV Res 5 November (6) (2007) 642-655
4. Vlasak J., and Ruprecht R.M. AIDS vaccine development and challenge viruses: getting real. AIDS 20 November (17) (2006) 2135-2140
5. Song R.J., Chenine A.L., Rasmussen R.A., Ruprecht C.R., Mirshahidi S., Grisson R.D., et al. Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C. Env J Virol 80 September (17) (2006) 8729-8738
6. Li J.T., Halloran M., Lord C.I., Watson A., Ranchalis J., Fung M., et al. Persistent infection of macaques with simian-human immunodeficiency viruses. J Virol 69 11 (1995) 7061-7067
7. Humbert M., Rasmussen R.A., Song R., Ong H., Sharma P., Chenine A.L., et al. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys. Retrovirology 5 (2008) 94
8. Rasmussen R.A., Hofmann-Lehman R., Montefiori D.C., Li P.L., Liska V., Vlasak J., et al. DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus. J Med Primatol 31 February (1) (2002) 40-60
9. Rasmussen R.A., Hofmann-Lehmann R., Li P.L., Vlasak J., Schmitz J.E., Reimann K.A., et al. Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques. AIDS 16 April (6) (2002) 829-838
10. Rasmussen R.A., Montefiori D.C., Robinson H.L., McClure H.M., and Ruprecht R.M. Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin. J Infect Dis 184 12 (2001) 1603-1607
11. Grisson R.D., Chenine A.L., Yeh L.Y., He J., Wood C., Bhat G.J., et al. Infectious molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination. J Virol 78 December (24) (2004) 14066-14069
12. Rasmussen R.A., Ong H., Kittel C., Ruprecht C.R., Ferrantelli F., Hu S.L., et al. DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in mice. Vaccine 24 March (13) (2006) 2324-2332
13. Andre S., Seed B., Eberle J., Schraut W., Bultmann A., and Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 72 February (2) (1998) 1497-1503
14. Rasmussen R.A., Ong H., Song R., Chenine A.L., Ayash-Rashkovsky M., Hu S.L., et al. Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges. AIDS 21 September (14) (2007) 1841-1848
15. Perkus M.E., Limbach K., and Paoletti E. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. J Virol 63 September (9) (1989) 3829-3836
16. Haffar O., Garrigues J., Travis B., Moran P., Zarling J., and Hu S.L. Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J Virol 64 June (6) (1990) 2653-2659
17. Hu S.L., Travis B.M., Garrigues J., Zarling J.M., Sridhar P., Dykers T., et al. Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus. Virology 179 November (1) (1990) 321-329
18. Polacino P.S., Stallard V., Klaniecki J.E., Pennathur S., Montefiori D.C., Langlois A.J., et al. Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques. J Virol 73 October (10) (1999) 8201-8215
19. Duvall M.G., Precopio M.L., Ambrozak D.A., Jaye A., McMichael A.J., Whittle H.C., et al. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol 38 February (2) (2008) 350-363
20. Hofmann-Lehmann R., Swenerton R.K., Liska V., Leutenegger C.M., Lutz H., McClure H.M., et al. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum Retroviruses 16 September (13) (2000) 1247-1257
21. Semba R.D., Kumwenda N., Hoover D.R., Taha T.E., Quinn T.C., Mtimavalye L., et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 180 July (1) (1999) 93-98
22. Barnett S.W., Lu S., Srivastava I., Cherpelis S., Gettie A., Blanchard J., et al. The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region. J Virol 75 12 (2001) 5526-5540
23. Beddows S., Schulke N., Kirschner M., Barnes K., Franti M., Michael E., et al. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J Virol 79 July (14) (2005) 8812-8827
24. Chakrabarti B.K., Kong W.P., Wu B.Y., Yang Z.Y., Friborg J., Ling X., et al. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J Virol 76 June (11) (2002) 5357-5368
25. Derby N.R., Kraft Z., Kan E., Crooks E.T., Barnett S.W., Srivastava I.K., et al. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection. J Virol 80 September (17) (2006) 8745-8762
26. Jeffs S.A., Goriup S., Kebble B., Crane D., Bolgiano B., Sattentau Q., et al. Expression and characterisation of recombinant oligomeric envelope glycoproteins derived from primary isolates of HIV-1. Vaccine 22 February (8) (2004) 1032-1046
27. Robinson Jr. W.E., Kawamura T., Gorny M.K., Lake D., Xu J.Y., Matsumoto Y., et al. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro. Proc Natl Acad Sci USA 87 8 (1990) 3185-3189
28. Yang X., Wyatt R., and Sodroski J. Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers. J Virol 75 3 (2001) 1165-1171